Eurides Isabel Fontes Lopes, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2426 Buhne St, Eureka, CA 95501 Phone: 707-443-4666 Fax: 707-445-4499 |
Uzi Moshe Selcer, MD Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 2280 Harrison Ave, Suite B, Eureka, CA 95501 Phone: 707-443-9371 |
News Archive
As many as 600,000 people are affected by deep vein thrombosis (DVT) and pulmonary embolism (PE) every year, and more than half of those are never diagnosed. Some people experience swelling and varying levels of discomfort in the affected area, and some don't feel anything at all. But the symptoms of DVT can be similar to other conditions, like a pulled muscle, and because some people with DVT do not have any symptoms, there is often a delay in diagnosis. That's when DVT can be fatal.
By comparing the DNA of patients with multiple sclerosis whose symptoms are reduced by interferon beta therapy to the DNA of those who continue to experience relapses, researchers may have identified important genetic differences between the two, according to an article posted online that will appear in the March 2008 print issue of Archives of Neurology.
Associate Professor Bruno van Swinderen from Queensland Brain Institute, University of Queensland with his colleagues have studied the workings of general anesthetics on the brain and found that these agents did more than just put a person to sleep. These findings could pave the way for better and more effective anesthetics they believe. The study was published in the latest issue of the journal Cell Reports.
Only recently has it become possible to create high-quality images of the brain plaques characteristic of Alzheimer's disease in living people through positron emission tomography (PET). Even so, questions remain about what can be learned from these PET images and which people should have this test.
› Verified 8 days ago